Browsing by Subject "Cardiovascular outcomes"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Vitamin D Deficiency, Inflammation, and Diminished Endogenous Regenerative Capacity in Coronary Heart Disease
    (Elsevier, 2024-01-04) Desai, Shivang R.; Ko, Yi-An; Liu, Chang; Hafeez, Zaki; Park, Jiwon; Faaborg-Andersen, Christian; Alvi, Zain; Alras, Zahran; Alkhoder, Ayman A.; Martini, Afif; Varughese, Anil; Ejaz, Kiran; Cheung, Brian; Wang, Maggie; Gold, Daniel A.; Gold, Matthew E.; Jain, Vardhmaan; Vatsa, Nishant; Islam, Shabatun J.; Almuwaqqat, Zakaria; Dhindsa, Devinder S.; Mehta, Anurag; Kim, Jonathan H.; Wilson, Peter; Waller, Edmund K.; Vaccarino, Viola; Quyyumi, Arshed A.; Medicine, School of Medicine
    Background: Vitamin D deficiency (VDD) is associated with coronary heart disease (CHD) and poor outcomes, but supplementation does not improve prognosis. VDD has been implicated in and may promote greater risk through inflammation and impaired progenitor cell function. Objectives: The authors examined VDD, high-sensitivity C-reactive protein (hsCRP), circulating progenitor cell (CPC) counts, and outcomes in patients with CHD. They hypothesized that the higher risk with VDD is mediated by inflammation and impaired regenerative capacity. Methods: A total of 5,452 individuals with CHD in the Emory Cardiovascular Biobank had measurement of 25-hydroxyvitamin D, subsets of whom had hsCRP measurements and CPCs estimated as CD34-expressing mononuclear cell counts. Findings were validated in an independent cohort. 25-hydroxyvitamin D <20 ng/mL was considered VDD. Cox and Fine-Gray models determined associations between marker levels and: 1) all-cause mortality; 2) cardiovascular mortality; and 3) major adverse cardiovascular events, a composite of adverse CHD outcomes. Results: VDD (43.6% of individuals) was associated with higher adjusted cardiovascular mortality (HR: 1.57, 95% CI: 1.09-2.28). There were significant interactions between VDD and hsCRP and CPC counts in predicting cardiovascular mortality. Individuals with both VDD and elevated hsCRP had the greatest risk (HR: 2.82, 95% CI: 2.16-3.67). Only individuals with both VDD and low CPC counts were at high risk (HR: 2.25, 95% CI: 1.46-3.46). These findings were reproduced in the validation cohort. Conclusions: VDD predicts adverse outcomes in CHD. Those with VDD, inflammation and/or diminished regenerative capacity are at a significantly greater risk of cardiovascular mortality. Whether targeted supplementation in these high-risk groups improves risk warrants further study.